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Abstract: The COVID-19 pandemic has highlighted the global imperative to address health inequities.
Observational studies are a valuable source of evidence for real-world effects and impacts of im-
plementing COVID-19 policies on the redistribution of inequities. We assembled a diverse global
multi-disciplinary team to develop interim guidance for improving transparency in reporting health
equity in COVID-19 observational studies. We identified 14 areas in the STROBE (Strengthening the
Reporting of Observational Studies in Epidemiology) checklist that need additional detail to encour-
age transparent reporting of health equity. We searched for examples of COVID-19 observational
studies that analysed and reported health equity analysis across one or more social determinants of
health. We engaged with Indigenous stakeholders and others groups experiencing health inequities
to co-produce this guidance and to bring an intersectional lens. Taking health equity and social
determinants of health into account contributes to the clinical and epidemiological understanding of
the disease, identifying specific needs and supporting decision-making processes. Stakeholders are
encouraged to consider using this guidance on observational research to help provide evidence to
close the inequitable gaps in health outcomes.
Keywords: health inequities; observational studies; COVID-19; guidelines; reporting; public health;
vulnerable populations
1. Introduction
“We are not all in the same boat. We are all in the same storm. Some are on super-
yachts. Some have just the one oar” [1]—Damian Barr.
The coronavirus disease (COVID-19) public health emergency has exacerbated pre-
existing social, political, and economic factors driving health inequities and led to an
increase in unjust and avoidable differences in health outcomes [2,3]. Furthermore, the
responses to the COVID-19 pandemic from healthcare systems, governments, and suprana-
tional actors have raised concerns about differential impacts across population groups [4–6].
The complex interplay of socio-political factors related to housing, employment, and public
health measures have led to excess risk and burden of COVID-19 among marginalised
communities [7–9]. For example, local inequalities in income and healthcare resources
promote virus propagation [10], and lack of public health capacity in low-income countries
hampers global coronavirus tracing [11].
Understanding the differential effects of COVID-19 on health outcomes is a prereq-
uisite to adopting efficient and fair measures within our societies [12]. Evidence shows
that an approach informed by an understanding of social determinants of health helps to
understand the incidence and outcomes of most diseases and to address the roots of health
inequities [13–15]. However, data examining the role of the social determinants of health
within the context of the COVID-19 pandemic have been less prominent than research
focusing on the biomedical paradigm [16,17]. A recent rapid review of COVID-19 studies
examining infection, health service use, and health outcomes, found a minority of studies
that had assessed outcomes according to social determinants of health [18]. Moreover,
social determinants are rarely incorporated into mathematical modelling studies, which
have achieved substantive importance in informing policy-makers about the impact of
disease and interventions in the population over time [19,20]. Thus, these studies may
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mask the differential exposure and effects across social determinants that are driving
systemic inequalities [21].
Health inequities are differences in health that are avoidable and unfair [22]. Struc-
tural and systemic inequities in opportunities for health shape vulnerability, defined as
exposure to risk, susceptibility to disease, and capability of individuals and communities to
respond [23]. For example, structural racism in medicine continues to have profound and
adverse impacts on health equity [24,25]. Moreover, a distinction can be drawn between
medical vulnerability (those infected individuals who experience poorer prognosis) and
functional vulnerability (those individuals who are more susceptible to infection but do
not necessarily have a worse prognosis [26]. Thoughtful reporting on sociodemographic
data and discussion of social-ethical issues can help reveal social barriers and facilitators to
inform evidence-based health policy [27]. The paucity of research examining the impact of
the social determinants of health on COVID-19-relevant outcomes may, in part, be due to a
lack of agreed criteria to identify populations experiencing vulnerability and information
should be reported. The PROGRESS-Plus framework provides a conceptual and practical
framework that researchers can use to improve the reporting of social determinants of
health. In short, PROGRESS-Plus is comprised of Place of residence (e.g., urban/rural area,
low and middle-income country), Race/ethnicity/culture/language, Occupation, Gender
or sex, Religion, Education, Socioeconomic status, Social capital, and other contextual
factors that facilitate disadvantage (e.g., disability) [28].
Social groups can experience vulnerability across multiple and intersecting PROGRESS-
Plus factors. For example, nursing home staff and home care workers who lack health
insurance are at high risk for exposure to coronavirus and differential healthcare access [29].
The PROGRESS-Plus framework is useful to systematically assess, synthesise, and present
the evidence on the effectiveness of interventions to reduce differential impacts of ex-
posures and interventions across social groups. For instance, our team has previously
developed a conceptual framework for identifying and mitigating inequitable harms of
COVID-19 lockdown measures [30].
Observational studies (cohorts, cross-sectional studies, case-control studies) are well-
suited to study questions related to understanding health inequities such as access, imple-
mentation, and adherence questions [31,32]. While well-conducted randomised clinical
trials (RCTs) are often perceived to be the gold standard for assessing the efficacy of an
intervention, observational studies provide evidence on long-term effects (e.g., safety)
and complementary evidence of real-world effects in which inequities modify community
effectiveness or implementation of interventions results in a redistribution of inequities at
the population level. In the case of COVID-19, observational studies can provide evidence
on the distribution of the uptake of vaccines in real-world settings across social factors
such as age, sex, and socioeconomic status as well as population effectiveness across these
factors [33]. Observational coronavirus-related investigations can address questions about
treatment acceptability, feasibility, or unconscious bias of healthcare providers. Observa-
tional research also provides insight into transmission dynamics, diagnosis, and prognosis.
Furthermore, observational evaluative studies are well-suited to study COVID-19 poli-
cies and other population-level interventions where evaluations capitalise on naturally
occurring variations in implementation. Observational research can also be used to study
the distribution of societal consequences on mental health, food insecurity, job loss, and
healthcare access [34–37].
The continued public health emergency posed by the pandemic and the unjust distri-
bution of the health and societal burden highlighted the vast inequities in diagnostics and
vaccinations as well as solutions, both within and between countries. This motivated our
global multi-disciplinary, multi-stakeholder team to develop interim guidance on trans-
parency in assessing health equity in observational studies related to COVID-19 [38,39].
Reporting guidelines are an important tool to reduce research waste and promote trans-
parency [40]. Endorsement of reporting guidelines results in more transparent report-
ing [41]. Although collecting social data is a prerequisite, reporting them is also essential
Int. J. Environ. Res. Public Health 2021, 18, 9357 4 of 12
to enable inequities in clinical and public health decisions to be targeted. We aim to
extend the well-known STROBE (Strengthening the Reporting of Observational Studies
in Epidemiology) reporting guidelines [42] to enhance transparent reporting of health
equity considerations.
Indigenous Peoples globally are a priority population for improving health equity,
with long-standing structural inequities and lack of access to essential health determinants,
including self-determination and connection to the land [43,44]. We engaged with Indige-
nous scholars, citizens, and stakeholders to co-produce this guidance and appraise its
relevance to research with Indigenous Peoples. Additional groups experiencing different
dimensions of health inequities were engaged throughout the project to bring an intersec-
tional lens. This engaged approach to partnership reinforces our aspiration to improve
accountability and social justice in observational studies.
2. Materials and Methods
To produce this interim guidance, we took the following steps: (1) conceptualization of
the project, (2) obtaining funding, (3) registering the protocol of the project, (4) engaging a
diverse team of knowledge users and citizens, (5) holding regular meetings, (6) working on
interim guidelines iteratively the interim using collaborative online platforms, (7) selecting
examples of COVID-19 observational studies examining any PROGRESS-Plus factor, and
(8) discussing the draft and the final manuscript.
The STROBE-Equity project is registered in the EQUATOR Network (Enhancing the
QUAlity and Transparency Of health Research) [38], co-led by four investigators (SF, JJ,
LM, VW) and funded by the Canadian Institutes of Health Research. The project is based
on the methods for developing reporting guidelines described by Moher et al. [45], with
modifications to include people with lived experience of inequity on the team, conduct
an author survey, and seek feedback through qualitative key informant interviews [46] in
order to co-produce this research with authentic partnerships that value different types of
knowledge and participation. To develop this interim guidance, we formed a core writing
team that met weekly and included members with expertise in Indigenous health research
(AA, DOL, SGN1, OD, AR, EG, VW, LM, SGN2, LS, MKS, SF, JJ, PT, JL). We reviewed
other checklists related to equity in research to develop items for the interim STROBE-
Equity guidelines. We reviewed the CONSORT (Consolidated Standards of Reporting
Trials)-Equity extension [47] which includes 16 extension items related to formulating
equity objectives, describing ethical procedures, reporting equity analyses and interpreting
equity findings. We assessed the SAGER (Sex and Gender Equity in Research) reporting
guidelines [48] and the PRISMA (Preferred Reporting Items for Systematic Reviews and
Meta-Analyses)-Equity guidelines [49], both of which contain items related to evaluating
equity in research [39]. We convened a citizen panel (HE, JT, RG) with lived experience of
health inequities who met monthly to seek their views and engage them as citizen co-leads
in designing the overall project. We then planned this study together, using conference
calls, email, and an online text processor for collaborative manuscript editing.
We searched for examples of COVID-19 studies using the L·OVE (Living OVerview of
Evidence) platform, a system that maps questions relevant for health decision-making to a
repository of studies developed by the Epistemonikos Foundation and conducts regular
updates searches on COVID-19 [50]. We used the health equity typology in development
to identify examples. Eligibility criteria were as follows: peer-reviewed COVID-19 obser-
vational studies, either descriptive or investigating associations between exposure and
health outcomes, which analysed and reported on health equity across any PROGRESS-
Plus factor. We chose examples to include different types of studies (e.g., prospective vs.
retrospective designs, elements of PROGRESS-Plus, sampling methods, focused and gap
approaches, inclusive of high-income vs. low-income countries, and topics). We consid-
ered feedback on the examples from our diverse stakeholder team regarding relevance to
patients, citizens, clinicians, researchers, decision-makers, and payers of health services
and research. We used these examples to inform our proposed interim STROBE-Equity
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guidance. We circulated the draft guidance with examples to our multidisciplinary, global
steering committees on technical oversight, knowledge users, Indigenous research, and
citizen and public engagement to engage broader feedback.
3. Results
We identified 14 areas in the STROBE checklist that need additional detail to encourage
transparent reporting of health equity (Figure 1). Table S1 (Supplementary material)
presents the full preliminary checklist of possible items for STROBE-Equity reporting
guidelines. These items include description of the population across relevant health equity
characteristics using the PROGRESS-Plus factors as well as sampling methods to reach and
include populations who experience vulnerability. As with CONSORT-Equity, informed
consent, research accountability, and ethics procedures need to be reported for all studies
that include populations who experience vulnerability and health inequities to promote
“never about us, without us”. Studies that include people experiencing inequity need to
report methods to determine the relevance of outcomes for these populations and collect
relevant socio-demographic and contextual information for analysis. Methods to analyse
differential exposure, differential susceptibility and differential capacity to respond need to
be planned and described. Finally, implications of exclusion, missingness, or exclusion of
people experiencing inequities need to be discussed.
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ethnicity/culture/language, Occupation, Gender or sex, Religion, Education, So ioeconomic status, Social capital,
and other contextual fac ors that facilitate isadvantage.
e identified examples of COVID-19 observational studies with an explicit focus
on evaluating effects across one or more PROGRESS-Plus factors and summarised these
examples of specific questions and transparent reporting of health equity considerations.
Table 1 displays examples of focused and gap approaches across PROGRESS-Plus factors in
low- and middle-income countries and high-income countries. We defined gap approach
as using subgroup analysis or meta-regression to explore differential effects, whereas
focused approach examines populations experiencing inequity to assess effectiveness of
interventions. The examples also include different types of observational studies detailed
in STROBE guidelines. Figure 2 summarises the risk for COVID-19 disease (exposure or
susceptibility—i.e., differential effect including infection and recovery) and implications
for healthcare access for each PROGRESS-Plus factor.
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The components of the PROGRESS-Plus framework are interdependent, and the
COVID-19 pandemic has made such interdependence explicit. For instance, South African
women have decreased health access compared to men, especially striking among women
without post-secondary education [63], or access to the COVID-19 vaccine when schedul-
ing relies on technology is challenging for rural areas and lower-income neighbourhoods
within high-income countries [64]. Interactions and intersections of the PROGRESS-Plus
factors may amplify disparities (e.g., race and gender, or level of education, incomes,
and work conditions), while some may mitigate the effect of others (e.g., social capital).
Supplementary material provides a comprehensive description of the rationale and rele-
vance to the COVID-19 pandemic and additional examples are also outlined in the Table S2
(Supplementary material).
4. Discussion
The COVID-19 pandemic has aggravated pre-existing inequities and their effects on
health outcomes and societal burden. This interim guidance proposes a structure for
applying an equity lens to observational studies by using the well-established PROGRESS-
Plus framework. The practical examples strive to illustrate equity considerations in clinical
and public health studies and ultimately guide key stakeholders interested in mitigating
health inequities. We identified 14 items across six domains of the STROBE checklist that
need to be adapted to ensure transparent reporting of health equity.
Western-oriented knowledge and approaches have often reproduced the dynamics
of structural oppression systems (racism, colonialism, patriarchy, capitalism, etc.) [65,66].
Thus, the evidence derived from these methodologies is at risk of disregarding the needs
of health care and values and preferences of most of the population that, in turn, is
composed of a diverse mosaic of groups experiencing multiple axes of disadvantage [67–69].
Addressing the social determinants of health as root causes of COVID-19 inequities also
involves health professional education, both in undergraduate and postgraduate stages,
which tends to explain the complex health–disease processes as mainly relying on the
biomedicine model. Medical conferences also need to integrate into the discussion of
biomedical information the etiopathogenic role and clinical and social consequences of
social determinants of health.
Over the last decades, a number of frameworks have advanced a better understanding
of differential health outcomes [48,70,71], highlighting the role of research in identifying
and addressing inequity [22,72]. Routine consideration of drivers of health inequities
contributes to generating evidence for accountability in evolving political, social, and
economic challenges and helps policymakers prioritise actions to maximize both overall
population health and the distribution of health in the population [73]. Moreover, frame-
works outlining unintended and inequitably distributed harmful impacts may facilitate
the development of mitigating strategies [30]. The integration of equity issues requires
creative approaches to capture different social dimensions and develop transformative
insights [71,74]. For example, training in the conduct of research with Indigenous com-
munities, and drawing attention to who is or is not involved in the research process,
including use of the GRIPP (Guidance for Reporting Involvement of Patients and Pub-
lic) [75] checklist or SAGER guideline [48] required by journals. Broadening research
communities and involving more diverse voices may contribute to integrating equity in
health research and subsequent decision-making [76,77]. Reporting guidelines have been
developed to assist researchers who conduct systematic reviews and RCTs in identifying,
extracting, and interpreting evidence on equity [47,49]. Given the fact that the impacts of
the COVID-19 pandemic are unevenly and unjustly distributed across groups, it may be
critical to appraise equity considerations in any observational investigation whose assessed
phenomena might influence health outcomes (e.g., examining unconscious bias regarding
racism among clinicians). The STROBE-Equity project is engaged in a comprehensive
process to enhance transparency and completeness of reporting of equity considerations in
observational studies. Acknowledging that this task requires engaging multiple stakehold-
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ers, we call upon interested clinicians, researchers, editors, funding agencies, the public,
and policy-makers to join by contacting us through our Open Science Framework project
(https://osf.io/h57se/) (accessed on 22 June 2021) [38].
5. Conclusions
Given the magnitude of inequities in health and the societal burden of COVID-19,
applying an equity lens to observational research can contribute to a better understanding
of who may experience vulnerability, including exposure to the virus, response to treat-
ment, community effectiveness, and the consequences of public health policies and other
measures. We propose this interim guidance as a structure for integrating an equity lens
within the design, analysis, and interpretation and reporting of results in observational
research. We identified 14 areas in the STROBE checklist that need additional detail to
encourage transparent reporting of health equity; we also described examples that anal-
ysed and reported on health equity across social determinants of health. This interim
guidance serves as a starting point for clinicians, researchers, decision-makers, and funders
in considering what needs to be reported to close the inequitable gaps in health outcomes.
The consensus process that is planned for STROBE-Equity extension will further develop
parsimonious, evidence-based guidance.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/ijerph18179357/s1, Table S1: Checklist of possible items for STROBE-Equity reporting
guidelines, Table S2: Additional examples of COVID-19 observational studies.
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